Home›People›Tommy Thompson
TT

Tommy Thompson

Director at Pleopharma.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Aug 10, 2026·Suggest an edit

About Tommy Thompson

Tommy Thompson is a director at Pleopharma.

Tommy Thompson reports to the SEC as a director or officer of 17 public companies, including United Therapeutics (UTHR), TherapeuticsMD (TXMD) and Healthpeak Properties (DOC).

Tommy Thompson first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name Tommy Thompson in the role, so the role may have started earlier or lasted longer.

Pleopharma, Inc.
Director
2025 – 2026 · Phoenixville, PA
Develops a drug for adults experiencing cannabis withdrawal.
United Therapeutics Corp.
Director
2010 – 2026 · Public company (UTHR)
TherapeuticsMD, Inc.
Chairman
2012 – 2025 · Public company (TXMD)
Healthpeak Properties, Inc.
Director
2024 – 2025 · Public company (DOC)
Physicians Realty Trust
Director
2013 – 2024 · Public company (DOC)
Scilex Holding Co
Director
2022 – 2023 · Public company (SCLX)
Centene Corp.
Director
2006 – 2022 · Public company (CNC)
Tyme Technologies, Inc.
Director
2018 – 2019 · Public company (TYME)
Bard C R Inc.
Director
2006 – 2018 · Public company (BCR)
Plus Therapeutics, Inc.
Director
2011 – 2016 · Public company (PSTV)
CareView Communications Inc
Director
2010 – 2014 · Public company (CRVW)
Vyant Bio, Inc.
Director
2013 · Public company (VYNT)
AGA Medical Holdings, Inc.
Director
2009 – 2010 · Public company (AGAM)
Emmaus Life Sciences, Inc.
Director
2009 – 2010 · Public company (EMMA)
Pure Bioscience, Inc.
Director
2006 – 2009 · Public company (PURE)
Spectrascience Inc.
Director
2007 · Public company (SCIE)
Positiveid Corp.
Director
2007 · Public company (PSID)
Medco Health Solutions Inc.
Director
2006 · Public company (MHS)

Key Colleagues at Startups

The people Tommy Thompson works with at each company, as listed on that company's latest Form D.

Pleopharma, Inc. · Form D, Aug 10, 2026
KT
Kyle Tomlin
Director
GC
Ginger Constantine
Executive officer and director
SH
Sarah Hassan
Director
JC
Jay Constantine
Chief Medical Officer, Co-Founder and Director
TP
Thomas Poche
Executive officer
DC
Daniel Cartwright
Chief Financial Officer
RF
Robert Finizio
Executive Director
PB
Paul Bisaro
Director
KM
Kyle Mowitz
Director
BS
Brij Sharma
Director

Sources

  1. SECPleopharma, Inc. Form D, filed Aug 10, 2026
  2. SECForms 3, 4 and 5 filed by Tommy Thompson (SEC filer 1324863)